ClinicalTrials.Veeva

Menu
S

Southeastern Clinical Research Institute, LLC | Augusta, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KBP-5074
Semaglutide
RGLS8429
TMX-049
Ferric Citrate
Epizon-701
EPN-701
Retatrutide
Finerenone
BAY3283142

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 14 total trials

A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

Primary Objectives* To assess the safety and tolerability of RGLS8429* To assess the impact of RGLS8429 on ADPKD biomarkersSecondary Objectives* To a...

Enrolling
ADPKD
Polycystic Kidney, Autosomal Dominant
Drug: Placebo
Drug: RGLS8429

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who hav...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Lepodisiran Sodium
Drug: Placebo

Researchers are looking for a better way to treat people who have chronic kidney disease (CKD), CKD is a condition in which the kidneys' ability to w...

Enrolling
Chronic Kidney Disease
Drug: BAY3283142
Drug: Placebo

Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finere...

Active, not recruiting
Non-diabetic Chronic Kidney Disease
Drug: Finerenone (BAY94-8862)
Drug: Placebo

The purpose of this study is to determine non-inferiority in safety and efficacy when Quanta SC+ is used in the self-care home environment compared t...

Active, not recruiting
Renal Failure
Device: SC+ Hemodialysis System

This study is an open-label, multi-center study evaluating the clinical utility of Renasight in the diagnosis and management of kidney disease.

Active, not recruiting
Kidney Diseases
Diagnostic Test: Renasight

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...

Enrolling
Overweight and Obesity
Drug: Retatrutide
Drug: Placebo

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Enrolling
Chronic Kidney Disease
Inflammation
Drug: Placebo (Ziltivekimab B)
Drug: Placebo (Ziltivekimab C)

Trial sponsors

Bayer logo
Lilly logo
Novo Nordisk logo
E
K
K
Merck KGaA (EMD Serono) logo
Natera logo
Q
R

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems